Sangamo Therapeutics Announces Second Quarter 2024 Conference Call and Webcast
July 30 2024 - 4:15PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that the company has scheduled the release
of its second quarter 2024 financial results after the market close
on Tuesday, August 6, 2024.
The company will hold a conference call at 4:30 p.m. Eastern on
Tuesday, August 6, which will remain open to the public. During the
conference call, the company will review its financial results and
provide business updates.
Participants should register for, and access, the call using
this link. While not required, it is recommended to join 10 minutes
prior to the event start. Once registered, participants will be
given the option to either dial into the call with the number and
unique passcode provided, or to use the dial-out option to connect
their phone instantly. The link to access the live webcast can also
be found on the Sangamo Therapeutics website in the Investors and
Media section under Events.
A replay will be available following the conference call,
accessible under Events.
About Sangamo Therapeutics
Sangamo Therapeutics is a genomic medicine company dedicated to
translating ground-breaking science into medicines that transform
the lives of patients and families afflicted with serious
neurological diseases who do not have adequate or any treatment
options. Sangamo’s zinc finger epigenetic regulators are ideally
suited to potentially address devastating neurological disorders
and Sangamo’s capsid discovery platform is potentially expanding
delivery beyond currently available intrathecal delivery capsids,
including in the central nervous system. Sangamo’s pipeline also
includes multiple partnered programs and programs with
opportunities for partnership and investment. To learn more, visit
www.sangamo.com and connect with us on LinkedIn and Twitter/X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240730067228/en/
Investor Relations & Media Inquiries Louise Wilkie
ir@sangamo.com media@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Oct 2023 to Oct 2024